BioCer’s primary scope is the development and production of plant based haemostatic materials, in order to assist medical professionals in the control of blood loss in a diverse range of complex surgical procedures. BioCer has also commercialized a unique advanced surface coating system made of titanium oxide, in order to improve the biocompatibility of surgical meshes for application in hernia repair and breast reconstruction.